DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced it would report its financial results for the fourth quarter and full year of 2008 on Tuesday, March 10, 2009 after the close of the financial markets. The announcement will be followed by a conference call with the investment community scheduled for the following morning, Wednesday, March 11, 2009, at 11:00 AM ET.
